Evidence map›Paper›PMID 31273316›Full record

ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2020

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.

Sanja Dacic, Nolwenn Le Stang, Aliya Husain, Birgit Weynand, Mary Beth Beasley, Kelly Butnor, David Chapel, Allen Gibbs, Sonja Klebe, Sylvie Lantuejoul and 5 more

Open access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Pleural mesothelioma classification-update and challenges.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  11. Review
  12. Pleural mesothelioma classification update.Virchows Archiv : an international journal of pathology · 2021
    Review
  13. Article
  14. Update on the pathologic diagnosis of malignant mesothelioma.Translational lung cancer research · 2020
    Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 5 countries.

Sanja DacicDepartment of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. dacics@upmc.edu.
Nolwenn Le StangMESOPATH, MESONAT, MESOBANK Department of BioPathology, Centre Leon Berard, Lyon, France.ORCID http://orcid.org/0000-0001-9522-6552
Aliya HusainDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Birgit WeynandDepartment of Pathology, UZ Leuven, Leuven, Belgium.
Mary Beth BeasleyDepartment of Pathology, Mount- Sinai Medical Center, New York, NY, USA.
Kelly ButnorDepartment of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA.
David ChapelDepartment of Pathology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-9733-5442
Allen GibbsDepartment of Cellular Pathology, University of Wales, Cardiff, UK.
Sonja KlebeDepartment of Anatomical Pathology, Flinders University, Adelaide, SA, Australia.
Sylvie LantuejoulMESOPATH, MESONAT, MESOBANK Department of BioPathology, Centre Leon Berard, Lyon, France.
Anja C RodenDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Victor RoggliDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Henry TazelaarMayo Clinic, Scottsdale, AZ, USA.
Jean-Michel VignaudMESOPATH, MESONAT, MESOBANK Department of BioPathology Centre Leon Berard, Lyon, France; CHU Nancy, INSERM U954, Université de Lorraine, Nancy, France.
Françoise Galateau-SalléMESOPATH, MESONAT, MESOBANK Department of BioPathology, Centre Leon Berard, Lyon, France.
Centre Léon Bérard · FRMayo Clinic in Arizona · USUniversity of Chicago · USDuke Medical Center · USFlinders University · AUInserm · FRMount Sinai Medical Center · USUniversitair Ziekenhuis Leuven · BEUniversity of Pittsburgh Medical Center · USUniversity of Vermont Medical Center · USUniversity of Wales · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The percentage of sarcomatoid component has an impact on prognosis in patients with biphasic malignant pleural mesothelioma. Recent study showed that the transitional pattern similar to sarcomatoid component of malignant mesothelioma has negative prognostic significance. Practice guidelines recommend quantification of sarcomatoid component despite poor diagnostic reproducibility of biphasic mesothelioma among thoracic pathologists. The aim of this study was to determine the interobserver agreement in the quantification of sarcomatoid component, and in the diagnosis of a transitional component in the biphasic malignant mesothelioma. Thirteen experts in thoracic pathology reviewed the representative H&E and cytokeratin whole-slide images of the 54 biphasic mesotheliomas, without knowledge of BAP1 or p16 deletion status, and completed the survey of 25 questions. The overall interobserver agreement in the assessment of the percentage of the sarcomatoid component in 25% increments was good (wK = 0.62). Excellent agreement was present in 14 of 54 cases (26%), and 3 cases were unanimously scored. Excellent agreement was reached for the cases with 0-24% and > 75% of the sarcomatoid component.The most commonly used criteria for the diagnosis of sarcomatoid component were malignant spindle cells, frank sarcomatoid features and high N/C ratio. The overall interobserver agreement for transitional pattern was fair (wK = 0.40). Unanimous opinion about the absence of transitional pattern was observed in only one case. At least 70% agreement regarding the presence of transitional pattern was observed in 12 cases, with the rest of the cases showing a wide range of disagreement. Morphologic characteristics that favor transitional pattern over non-transitional include sheet-like growth of cohesive, plump, elongated epithelioid cells with well-defined cell borders and a tendency to transition into spindle cells. Our study defined precise morphologic criteria that may be used in the differential diagnosis between transitional pattern and other mesothelioma subtypes including sarcomatoid and epithelioid.

Indexed as

PathologistsBiopsyDiagnosis, DifferentialHumansMesothelioma, MalignantNeoplasms, Complex and MixedObserver VariationPleural NeoplasmsPredictive Value of TestsReproducibility of ResultsSarcoma

Identifiers

PMID31273316
OpenAlexW2954859452

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.